AYOXXA Biosystems Company
AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.
Technology:
Diagnostics
Headquarters:
Singapore (2010), Germany (2012)
Funding Status:
Series B
Founded Date:
2010
Employee Number:
11-50
Industry:
Personalized Medicine